Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | HTT | P42858 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | PDE1A | P54750 | 1/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28817475 | 0.75 | LMNA (0.41) | SMN1; SMN2LMNAHTTTSHRMAPT | |
| SCHEMBL2512278 | 0.73 | — | — | |
| SCHEMBL27624956 | 0.71 | — | — | |
| SCHEMBL6855316 | 0.71 | CYP19A1 (0.47) | SMN1; SMN2LMNAHTTTSHRMAPT | |
| SCHEMBL27846602 | 0.71 | — | — | |
| SCHEMBL27306894 | 0.71 | — | — | |
| SCHEMBL27353368 | 0.71 | — | — | |
| Ethane SCHEMBL28231212 | 0.70 | LMNA (0.36) | SMN1; SMN2LMNAHTTTSHRMAPT | |
| SCHEMBL28037377 | 0.70 | LMNA (0.38) | SMN1; SMN2LMNAHTTTSHRMAPT | |
| SCHEMBL23994635 | 0.68 | CYP19A1 (0.39) | SMN1; SMN2LMNAHTTTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240203727-A1 | METHOD OF DEPOSITING SILICON-BASED MATERIAL AND PRECURSORS FOR THE SAME | ASM IP HOLDING B.V. (NL) | 2024-06-20 | — | — | US | disclosed |
| CN-118207515-A | Method for depositing silicon-based materials and precursors thereof | ASM IP私人控股有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-6335456-B1 | REACTING AN AMIDE WITH SILYLATION AGENT; DISTILLATION | ATOFINA (FR) | 2002-01-01 | — | — | US | disclosed |
| US-20010056200-A1 | Semi-continuous process for preparing bis-silyl carboxamides | ATOFINA (FR) | 2001-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056200-A1 | Semi-continuous process for preparing bis-silyl carboxamides | ACMSD, BRD4, BICRA | SMN1; SMN2 1131/4885LMNA 265/4885HTT 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.